Early in 2008, Guan and co-workers [98] reported 2,3,5,4′-tetrahydroxystilbene-2-O-β-d-glucoside (THSG) (Figure 28) as tyrosinase activator andmelanogenesisstimulator without cytotoxicity in B16 melanoma cells. This evidence concerns the gene TYR and melanoma.